Further research on the working mechanisms of YB-1 in exosomes for GC angiogenesis are warranted, and more clinical studies could be done to reveal whether YB-1 can be a potential biomarker for predicting invasion or metastasis in GC. Here, YBX1 is linked to gastric cancer.